MENLO PARK, California
June 14, 2013
Auxogyn announces the birth of the first baby in
to be born using a ground-breaking new approach to IVF, the 'Early Embryo Viability Assessment' (
) test, that improves embryo selection.
and photos available at 10am BST
today, the world's first baby to be born and named by her parents after the new Eeva test. Eva was born on 11
hardship of trying to build a family together. Susan and David chose to have the Eeva test at the GCRM to increase their chances of IVF success. The new mother, Susan said "we wanted every chance to be successful, so we chose Eeva."
The Eeva test uses unique predictive software in combination with a time-lapse analysis technique to automatically analyse embryo development against scientifically and clinically validated cell-division parameters. The test aids embryologists in selecting the most viable embryos for transfer, potentially increasing the chances of a successful IVF cycle.
"We are delighted to hear the news of this healthy birth and wish the family the very best," said
, President and CEO of Auxogyn. "The Eeva test has been developed to give IVF clinicians objective information about the embryo and provide insight into its growth potential. With more couples choosing to use Eeva, we are looking forward to many more births like
at GCRM said: "We are very proud to be among the first clinics in the world to announce this news as it demonstrates how successful this new technology can be in enabling couples to have a higher chance of conceiving a baby with IVF. GCRM has always strived to be one of the leading IVF Centres in
, offering couples the latest innovations and best possible outcomes. The Eeva test is the practical end point of good quality research and is the start of a new chapter in the evolution of IVF."